Advertisement

Jansen Jab Gets The EMA’s Go Ahead

The benefits of the Johnson & Johnson Covid-19 vaccine outweigh the risks - that’s what the...

Share this article

09.41 21 Apr 2021


Jansen Jab Gets The EMA’s Go Ahead


Listen to this episode


Share this article

09.41 21 Apr 2021


The benefits of the Johnson & Johnson Covid-19 vaccine outweigh the risks - that’s what the European Medicines Agency concluded yesterday. Concerns about the Jansen jab’s safety had been raised following reports of a small number of blood clots in US recipients. Professor of Experimental Immunology at Trinity College Dublin, Kingston Mills joined us this morning.

Listen and subscribe to Newstalk Breakfast on Apple Podcasts or Spotify.

   

Download, listen and subscribe on the Newstalk App.

  

You can also listen to Newstalk live on newstalk.com or on Alexa, by adding the Newstalk skill and asking: 'Alexa, play Newstalk'.


Read more about

Breakfast Covid Vaccine Jansen Vaccine Johnson And Johnson Newstalk Newstalk Breakfast Vaccine

Related Episodes

Construction industry could be...

00:07:38

Construction industry could be another victim of rising fuel prices

The Hard Shoulder

00:07:38


Two pilots die after jet colli...

00:03:34

Two pilots die after jet collides with fire truck in New York

The Hard Shoulder

00:03:34


Why do we care about Daylight...

00:11:19

Why do we care about Daylight Saving Time?

The Hard Shoulder

00:11:19


Kids Clinic: Developmental Mil...

00:08:10

Kids Clinic: Developmental Milestones

The Hard Shoulder

00:08:10